RNA Manufacturing Videos

31. Leading The Genomic Medicine Revolution 4/13/2022

    We work with the world’s leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine.

32. Regulatory Concerns In mRNA Therapeutic Development 3/31/2022

    In this segment of the BioProcess Online Live event CMC, SCALE UP, & THE ROAD TO mRNA REGULATORY APPROVAL, panelists Akhilesh Bhambhani, Sr. Director, Biologics Drug Product Development at Ultragenyx Pharmaceuticals and Roberta Duncan, VP and mRNA Program Lead at Seqirus share early learnings on the regulatory path.

33. Optimize DNA Storage Using Dedicated Fluoropolymer Film 5/9/2023

    Discover how to integrate appropriate materials and tools for oligonucleotide handling, optimize DNA storage using dedicated fluoropolymer film, perform complex biochemical reactions in bags, and more.

34. New Approaches For Targeted Drug Delivery With Nanomedicines 4/13/2022

    Nanomedicine is a branch of medicine that seeks to apply nanotechnology for disease prevention and/or treatment, imaging, diagnosis, monitoring, and the repair and regeneration of biological systems.

35. Bio4C ProcessPad™ Product Overview 5/19/2020

    Introducing Bio4C ProcessPad™ Software, part of the BioContinuum™ Platform.

36. Translation Of RNA Nanomedicines From Design To Clinical 4/14/2022

    mRNA therapeutics are applicable to cancer immunotherapies, infectious diseases, and other indications that require protein replacement therapy or antibodies.

37. What Does 2025 (And Beyond) Hold For The RNA-LNP Space? 12/4/2024

    Three LNP experts share their thoughts on the incremental advancements they’d like to see the RNA-LNP space make in the next few years.

38. Laboratory Filtration Products For Clone Selection, Optimization And Recombinant Protein Analysis 2/8/2023

    See how Pall innovative and time-saving life science research products simplify and speed up your critical workflow steps and allow for faster data analysis and results.

39. Risk Reduction In mRNA Therapeutic Development: Meet The Panel 10/16/2023

    Listen in on a discussion reviewing key drivers behind the flurry of activity in mRNA therapeutic development and begin to address the rate-limiting risks to mRNA therapeutic development.

40. MilliporeSigma Bio-Expo Live February 2025: Downstream Bioprocessing 3/17/2025

    Advancements in single-use technologies are transforming antibody-drug conjugate manufacturing and offering increased flexibility. Examine key data, design considerations, operational benefits, and applications in ADC production.